ResearchPeptide
Selank
Published Research
PubMed-indexed studies for Selank
Selank, a Peptide Analog of Tuftsin, Attenuates Aversive Signs of Morphine Withdrawal in Rats.
View on PubMed →Efficacy of peptide anxiolytic selank during modeling of withdrawal syndrome in rats with stable alcoholic motivation.
View on PubMed →Peptide Selank Enhances the Effect of Diazepam in Reducing Anxiety in Unpredictable Chronic Mild Stress Conditions in Rats.
View on PubMed →[The role of opioid system in peculiarities of anti-anxiety effect of peptide anxiolytic selank].
View on PubMed →Selank, Peptide Analogue of Tuftsin, Protects Against Ethanol-Induced Memory Impairment by Regulating of BDNF Content in the Hippocampus and Prefrontal Cortex in Rats.
View on PubMed →Peptide-based Anxiolytics: The Molecular Aspects of Heptapeptide Selank Biological Activity.
View on PubMed →Research-Grade Selank
⚠️ For laboratory research only. Not for human use.